Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SRPTSRPT
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in SAREPTA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 2M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $36.7M as of 2026-Q2. The position was increased (+89.4% shares). SRPT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$36.7M

Current Shares

2M

Total Value Change

-$21.3M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+89.4%
$36.7M0.0%$17.97
46
2026-Q1
Increased
1.1M
+91.3%
$23.5M0.0%$15.87
45
2025-Q4
Increased
563,486
+218.1%
$12.1M0.0%$21.49
45
2025-Q3
Decreased
177,151
-52.9%
$3.4M0.0%$18.82
0
2025-Q2
Increased
376,284
+106.7%
$6.4M0.0%$17.11
44
2025-Q1
Decreased
182,075
-61.8%
$11.6M0.0%$70.41
0
2024-Q4
New
477,066
-
$58M0.0%$121.19
41

Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Janus Henderson Group Ltd., BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used